Brazil represents one of the largest pharmaceutical markets in the world, ranking among the top ten globally and leading the Latin American region. Over the past decade, the sector has witnessed steady growth, driven by increasing healthcare investments, rising disposable incomes, and a growing middle class. As the world’s sixth-most populous country, Brazil offers a
Author Archives: Wagner Moi
The pharmaceutical industry in Brazil continues to experience rapid growth, driven by demand for innovative therapies and increasing healthcare access. While that growth presents new opportunities for pharmaceutical companies, navigating the evolving regulatory environment poses significant challenges for companies seeking to bring new products to market. At the heart of the process lies ANVISA (Agência